Atea Pharmaceuticals Inc (NAS:AVIR)
$ 3.71 -0.25 (-6.31%) Market Cap: 312.47 Mil Enterprise Value: -242.18 Mil PE Ratio: 0 PB Ratio: 0.60 GF Score: 43/100

Q4 2020 Atea Pharmaceuticals Inc Earnings Call Transcript

Mar 30, 2021 / 08:30PM GMT
Release Date Price: $56.23 (-4.13%)
Operator

Good afternoon, ladies and gentlemen. Welcome to the Atea Pharmaceuticals' Full Year 2020 Financial Results Conference Call. (Operator Instructions)

I would now like to turn the call over to Jonae Barnes, Senior Vice President of Investor Relations and Corporate Communications at Atea Pharmaceuticals. Please proceed.

Jonae R. Barnes
Atea Pharmaceuticals, Inc. - SVP of IR & Corporate Communications

Great. Thank you, operator. Good afternoon, everyone, and welcome to Atea Pharmaceuticals' Full Year 2020 Financial Results Conference Call. Earlier today, we issued a press release which outlines the topics we plan to discuss. You can access the press release as well as the slides that we'll be reviewing today by visiting the Investors section of our website at ir.ateapharma.com.

With me today from Atea, our Founder, Chairman and Chief Executive Officer, Dr. Jean-Pierre Sommadossi; Chief Development Officer, Dr. Janet Hammond; and Chief Financial Officer and Executive President of Legal, Andrea Corcoran. Our Chief Commercial Officer, John

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot